Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Diane Zuckerman is president of the National Center for Health Research, a nonprofit that monitors FDA device policy. Speaking to the Times, she said she said Tarver is focused on patient safety and ...
Results that may be inaccessible to you are currently showing.